Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Share News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 328.00
Bid: 325.50
Ask: 330.00
Change: 28.00 (9.33%)
Spread: 4.50 (1.382%)
Open: 304.00
High: 350.00
Low: 303.00
Prev. Close: 300.00
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EXECUTIVE CHANGES: Oxford BioMedica adds former Teva exec to board

Thu, 15th Jul 2021 14:54

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Wednesday and Thursday and not separately reported by Alliance News:

----------

Mitchells & Butlers PLC - Birmingham, England-based operator of pubs, bars and restaurants - Says non-executive directors Colin Rutherford and Imelda Walsh will step down from the board on Monday next week, while Ron Robson will depart as a non-executive director on July 31. Mitchells & Butlers had announced the three departures back in May as part of a reduction in the size of its board to nine members.

----------

Salt Lake Potash Ltd - Western Australia-focused organic sulphate of potash miner - Hires Stuart Fraser as chief financial officer. Fraser most recently was chief accounting officer at oil field services firm Weatherford International, having previously worked for peer Schlumberger.

----------

Oxford BioMedica PLC - Oxford, England-based gene and cell therapy company - Hires Michael Hayden as non-executive director, starting Thursday. Hayden is a Canadian who has founded five biotechnology companies and also served as president of Global R&D & chief scientific officer at Israel-based Teva Pharmaceuticals Industries Ltd from 2012 to 2017.

----------

Everyman Media Group PLC - operates fourth largest cinema chain in UK by number of venues - Hires Maggie Todd as independent non-executive director, effective immediately. Todd was vice president of Communications for Walt Disney Studios Motion Pictures in Europe for 12 years. She also worked at Twenty Century Fox.

----------

BMO Capital & Income Investment Trust PLC - investment trust with portfolio consisting mainly of FTSE All-Share companies - Senior Independent Director Clare Dobie retires, having served on the board since 2012. Tim Scholefield appointed senior independent director in her place.

----------

Troy Income & Growth Trust PLC - invests predominantly in UK equities - Hires Brigid Sutcliffe as non-executive director, starting August 1. Sutcliffe is a chartered accounting who worked in investment banking and as a management consultant. Jann Brown will retire from the board in January, having served for nine years, and Sutcliffe will take over as chair of the Audit Committee at that time.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
22 Sep 2021 07:03

Oxford Biomedica swings to profit on Covid-19 vaccine sales

(Sharecast News) - Covid-19 vaccine producer Oxford Biomedica swung to a profit in the half year on the back of a surge in revenues through its partnership deal with AstraZeneca and announced that Serum Institute of India has agreed to invest £50m in the group in return for a 3.9% stake in the company.

Read more
21 Sep 2021 09:14

UPDATE 2-FTSE 100 recovers 1% on energy, healthcare stock boost; Entain jumps

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* Kingfisher top FTSE 100 loser despite positive results* Royal Dutch Shell sells U.S. oilfield assets* Stagecoast surges on merger talks wit...

Read more
15 Sep 2021 16:05

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
6 Aug 2021 10:55

ReNeuron taps Oxford Biomedica executive Catherine Isted as CFO

ReNeuron taps Oxford Biomedica executive Catherine Isted as CFO

Read more
28 Jul 2021 12:49

UK wants world vaccinated by middle of 2022, Raab says

OXFORD, England, July 28 (Reuters) - British Foreign Secretary Dominic Raab warned that the world would not be vaccinated until 2024 under current rates and urged other countries to join Britain in donating shots to poorer nations to bring that d...

Read more
15 Jul 2021 09:45

BROKER RATINGS: Citigroup prefers Beazley over Hiscox and Lancashire

BROKER RATINGS: Citigroup prefers Beazley over Hiscox and Lancashire

Read more
6 Jul 2021 15:52

IN BRIEF: Oxford BioMedica exec sells shares after options exercise

IN BRIEF: Oxford BioMedica exec sells shares after options exercise

Read more
24 Jun 2021 09:49

BROKER RATINGS: Deutsche raises GSK; HSBC cuts BP to Hold

BROKER RATINGS: Deutsche raises GSK; HSBC cuts BP to Hold

Read more
21 Jun 2021 09:34

BROKER RATINGS: UBS cuts Rio Tinto to Sell; Morgan Stanley ups Ocado

BROKER RATINGS: UBS cuts Rio Tinto to Sell; Morgan Stanley ups Ocado

Read more
18 Jun 2021 14:26

AstraZeneca must use Britain's plant if needed to meet EU's vaccine commitments - EU lawyer

June 18 (Reuters) - AstraZeneca must deliver COVID-19 vaccines to the European Union also from a factory in Britain if it is needed to meet its commitments with the EU, a judge ruled on Friday, according to a lawyer representing the EU.The company...

Read more
18 Jun 2021 14:06

UPDATE 5-EU loses bid for speedier AstraZeneca vaccine deliveries

* Judge orders AstraZeneca to deliver doses by strict deadlines* EU had asked for more doses to be shipped earlier* AstraZeneca may have breached contract in reserving doses for UK* Second legal case will establish whether contract was breached (...

Read more
28 May 2021 19:41

TRADING UPDATES: Odyssean IT swings to profit; BMO Cap ups dividend

TRADING UPDATES: Odyssean IT swings to profit; BMO Cap ups dividend

Read more
27 May 2021 17:27

EXECUTIVE CHANGES: Vectura senior director departs amid takeover offer

EXECUTIVE CHANGES: Vectura senior director departs amid takeover offer

Read more
25 May 2021 15:50

DIRECTOR DEALINGS: Renalytix AI CEO sells USD2 million in shares

DIRECTOR DEALINGS: Renalytix AI CEO sells USD2 million in shares

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.